Uterine serous carcinoma

Uterine Serous Carcinoma

File:Uterine papillary serous carcinoma low mag.jpg

Low magnification micrograph of uterine serous carcinoma.

File:Uterine serous carcinoma high mag.jpg

High magnification micrograph of uterine serous carcinoma.

File:Histopathology of serous carcinoma of uterus.jpg

Histopathology of serous carcinoma of the uterus.

File:Serous carcinoma cytology.jpg

Cytology of serous carcinoma.

Uterine serous carcinoma is a type of endometrial cancer that is characterized by its aggressive nature and poor prognosis. It is a subtype of endometrial carcinoma and is distinct from the more common endometrioid carcinoma.

Pathophysiology

Uterine serous carcinoma arises from the endometrium, the lining of the uterus. Unlike endometrioid carcinoma, which is often associated with estrogen exposure, uterine serous carcinoma is not typically linked to hormonal factors. It is thought to develop from endometrial intraepithelial carcinoma (EIC), a precursor lesion.

Clinical Presentation

Patients with uterine serous carcinoma often present with postmenopausal vaginal bleeding. Due to its aggressive nature, the cancer may have already spread beyond the uterus at the time of diagnosis. Other symptoms may include pelvic pain and ascites.

Diagnosis

Diagnosis is typically made through a combination of endometrial biopsy, imaging studies, and histopathological examination. On microscopic examination, uterine serous carcinoma is characterized by papillary structures and high-grade nuclear atypia.

Treatment

The treatment of uterine serous carcinoma often involves a combination of surgery, chemotherapy, and radiation therapy. Surgical management usually includes a hysterectomy with bilateral salpingo-oophorectomy and staging procedures. Due to the high risk of recurrence, adjuvant chemotherapy and radiation therapy are commonly employed.

Prognosis

The prognosis for uterine serous carcinoma is generally poor compared to other types of endometrial cancer. This is due to its aggressive nature and tendency to present at an advanced stage. The five-year survival rate is significantly lower than that for endometrioid carcinoma.

Related Pages

• Endometrial cancer
• Endometrial carcinoma
• Hysterectomy

• Uterine papillary serous carcinoma, low magnification
  Uterine papillary serous carcinoma, low magnification
• Uterine serous carcinoma, high magnification
  Uterine serous carcinoma, high magnification
• Histopathology of serous carcinoma of uterus
  Histopathology of serous carcinoma of uterus
• Serous carcinoma cytology
  Serous carcinoma cytology